A hamster monoclonal antibody (mAb) recognizing an epitope in the Vy1 Jy4-Cy4 chain of the y/8 T cell receptor has been generated. Using this mAb, we have quantitated the occurrence of Vyl-bearing y/8 T cells in the developing thymus and in the lymphoid organs and several epithelia ofadult mice. The Vyl-expressing cells constitute a minor y/8 T cell subpopulation during fetal and early postnatal life, but they constitute a major population of 'Y/8 T cells in the thymus and in the peripheral lymphoid organs in adult mice. In addition, we found that Vy1-bearing cells comprise a large proportion (15-60%) of the y/8 T cells present in the intestinal epithelium (i-IEL) in all strains of mice tested. Vy1 + i-IEL are present in athymic (nude) mice and in antigen-free mice, demonstrating that they can develop extrathymically and that their presence in the intestinal epithelium is independent of the antigenic load of the gut . Our results show that Vyl-bearing lymphocytes account for the largest population of y/8 T cells in the mouse. This population includes a thymus-dependent component that homes to the secondary lymphoid organs and a thymus-independent component that constitutes a major fraction of the y/8 i-IELs.
T lymphocytes bearing the y/8 TCR constitute a minor T cell subpopulation in the thymus and in the peripheral lymphoid organs but are often the major T cell type in epithelial tissues (1-9) . y/8 T cells comprise several different subsets as defined by such distinctive parameters as TCR repertoire, time of appearance during ontogeny, thymus dependence, and anatomical localization (for review, see reference 10). The physiological role of y/8 T cells is still poorly understood, partially because of the lack of knowledge about y/8 T cell ligands.
A large fraction of y/8 T cell hybridomas expressing a TCR composed of Vy1 Jy4-Cy4 and V86-C8 chains is constitutively activated to secrete IL-2 (11) . The role of a specific interaction involving the TCR in this activation has been suggested by the ability of mAbs against the TCR-CD3 complex to inhibit spontaneous IL-2 production and by the fact that transfection of the Vyl/V86 cDNAs into a TCR -murine hybridoma confers the phenotype ofconstitutive activation onto the recipient cells (11, 12) . In some cases, the reactivity of Vy1/V86 TCR-expressing hybridomas to purified protein derivative (PPD)' and to the 180-196 amino acid region of the mycobacterial heat shock protein ' Abbreviations used in this paper: AgF, antigen free ; DEC, dendritic epidermal cells ; HSP, heat shock protein ; i-IEL, intestinal intraepithelial lymphocytes ; PPD, purified protein derivative ; SPF, specific pathogen free.
(HSP) 60 has been demonstrated (13), although failures to detect such reactivities have also been reported (14, 15) . Constitutively activated hybridomas expressing the Vyl/ V86 TCR have been isolated from newborn and adult thymus (11, 14, 16) , adult spleen (16) , liver (17) , skin epidermis (18) , and from the intestinal epithelium ofweanling mice (15), suggesting that y/8 T cells expressing the Vyl gene product are normally present in different lymphoid organs and epithelia . Nevertheless, neither quantification of Vylbearing y/8 T cells in different tissues nor studies on the origin of these cells has been performed, mainly because of the lack of mAbs specifically recognizing this population . Here we describe a hamster mAb (named 2.11) specific for the mouse Vyl-Cy4 protein and the studies performed to analyze these issues . Our results show that Vy1-bearing lymphocytes account for the largest population of y/8 T cells in the mouse, including a thymus-dependent component that localizes to the secondary lymphoid organs and a thymus-independent component that comprises a significant fraction of the y/8 intestinal intraepithelial lymphocytes (i-IEL) .
Materials and Methods
Animals . C57BL/6 (B6), BALB/c, DBA/2, and C3H/Hej (C3H) mice were obtained from The Jackson Laboratory (Bar Harbor, ME) or from Ifha-Credo (L'Arbresle, France). BALB .B10 and BALB .C-3H mice were purchased from Bomholtgard Breeding and Research Center Ltd. (Bomholtvej, Denmark) and bred at the MIT facilities . BALB/c specific pathogen-free (SPF) and antigen-free (AgF) animals were a kind gift of Dr . C. Heusser (Ciba-Geigy, Basel, Switzerland) . Athymic (nu/nu) and (nu/+) littermates were purchased from The Jackson Laboratory, Charles River Laboratories, Inc. (Wilmington, MA), and Iffa-Credo. All other mouse strains were purchased from The Jackson Laboratory . Adult Armenian hamsters were obtained from Cytogen (West Roxbury, MA).
Abs . For complement-mediated killing, we used anti-CD4 (RL.174 ; reference 19) and anti-CD8 (HO 2.2 ; 20) . Both mAbs were used as culture supernatants. Other mAbs used were H57-597, anti-C[3 (21) ; GK1 .5, anti-CD4 (22), 53-6 .7, anti-CD8 (23) ; RA3.6B2, anti-CD45R/13220 (24) ; M1/70 anti-Mac-1 (25) 3A10, anti-8 (2), and 536 anti-Vy5 (26) . All of these mAbs were purified from culture supernatant either by ion exchange chromatography on DEAE-cellulose or by affinity chromatography on protein A-Sepharose (Pharmacia, Uppsala, Sweden) and biotinylated by standard procedures . Biotin-labeled goat anti-mouse IgM was purchased from Caltag Laboratories (San Francisco, CA); biotinlabeled anti-CD5 was from Becton Dickinson & Co . (Mountain View, CA); and FITC-labeled anti-CD8[3, FITC-labeled antiThyl, biotin-labeled anti-V84, and biotin-labeled anti-Vy4 were from PharMingen (San Diego, CA).
Immunofluorescence Staining and Flow Cytometric Analysis . Cells (105-10 6) were incubated in staining buffer (PBS, 3% FCS, 0.1% NaN3) with the indicated labeled Abs for 30 min on ice. After two washes, the cells were incubated with streptavidin-PE (Southern Biotechnology Associates, Birmingham, AL) for 15 min on ice. After another two washes, 10,000 viable cells were analyzed using a FACScan© flow cytometer (Becton Dickinson & Co .) . Dead cells were gated out by their staining with propidium iodide .
Cell Purifications and Cultures . The preparation of dendritic epidermal cells (DEC) and i-IEL has been previously described in detail (27, 28) . The preparation of y/8 T cell blasts used to produce y/8 T cell hybridomas was as follows: Thymus and spleen cell suspensions were prepared according to standard procedures . Thymocytes were incubated with biotinylated anti-CD4 and anti-CD8 mAbs, and splenocytes were incubated with biotinylated anti-TCR-[3, anti-CD4, anti-CD8, anti-13220, and anti-MAC-1 mAbs for 35 min on ice. After washing the unbound Abs, the cells were incubated with Tonsyl-activated magnetic beads (Dynal Inc., Great Neck, NY) that had been previously coupled to streptavidin according to the manufacturer's instructions . The incubation was performed for 60 min at 4°C with a slight rocking of the tubes. After separation of the beads, unbound cells were cultured in complete medium (DME supplemented with L-glutamine, sodium pyruvate, [3-ME, nonessential amino acids, penicillin, and streptomycin, plus 10% fetal bovine serum) together with irradiated (1,000 rad) B6 spleen cells (2 X 10 6/ml) in the presence of 50 lr,g/ml of PPD and 10 U/ml of rIL-2. Alternatively, thymocytes were treated with anti-CD4 and anti-CD8 mAbs and complement for 45 min at 37°C . CD4-CD8-live cells were purified by density gradient centrifugation using Lympholyte M (Cederlane Laboratories, Ltd., Hornby, Ontario, Canada) and cultured (5 X 105/ml) in complete medium plus 10 U/ml of rIL-2, in plates previously coated with the 2.11 mAb (20 Wg/ml) .
Production of T Cell Hybridomas. 3-5 d after initiation o£ the cultures described above, growing blasts were fused to the TCRa/[3 -variant of the BW5147 thymoma cell line (29) at a 1 :1 ratio in 0.5 ml of 50% polyethylene glycol as described (30) . The cells   1922 were then distributed in 96-well flat-bottomed plates with either HAT or azaserine-hypoxanthin medium . The hybridomas named T and S come from PPD-stimulated thymocytes and splenocytes, respectively. The hybridomas named BTC come from thymocytes activated with the 2.11 mAb.
Production of the 2 .11 mAb . Armenian hamsters were immunized intraperitoneally three times at 3-wk intervals with 2 X 10 6-10' irradiated, TCR y/8+ T3 .13.1 hybridoma cells resuspended in saline . The T3 .13.1 hybridoma expresses a TCR composed of Vy1 and V86.3 chains and constitutively secretes IL-2 when cultured in vitro. 3 d after the last injection, spleen cells were fused with the murine myeloma SP2/0 at a ratio of 10 :1 (spleen cell/ myeloma) in 1 ml of 50% polyethylene glycol as described (2) . The cells were then distributed in 96-well flat-bottomed plates with HAT medium . Culture supernatants from growth-positive wells were tested for their ability to inhibit the constitutive IL-2 production of the immunizing hybridoma. IL-2 production was assayed by the growth of the HT-2 cells, scored by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-2H-tetrazolium bromide) assay as originally described (31) . Cells from wells inhibiting >75% of the IL-2 secretion were subcloned several times by limiting dilution until stable Ab-secreting hybrids were obtained .
Cell Surface Labeling and Immunoprecipitation . 8 X 106 Vylexpressing hybridoma cells were harvested by centrifugation, washed four times with PBS, and resuspended in 4 ml of PBS. Cells were split into nine glass test tubes coated with Iodogen (Pierce, Rockford, IL), and 200 p,Ci Na'ZS I was added to each tube . After a 15-min incubation on ice with occasional mixing, cells were pooled and washed four times with PBS . The cell pellet was lysed in 1 .5 ml ice cold lysis buffer (10 mM Tris-HCI, pH 7.6, 150 mM NaCl, 1% Triton X-100, I mM PMSF), vortexed for 20 s, and incubated on ice for 30 min. The lysate was clarified by centrifugation at 13,000 rpm at 4°C in a microfuge. 0.1 vol of normal hamster serum was added to the supernatant, followed by two rounds of preclearing with 0.1 vol protein A-Sepharose beads (Pharmacia) . One quarter of the precleared lysate was immunoprecipitated with 10 Id of either 2.11-or 3A10-coated protein A-Sepharose beads. Immunoprecipitates were washed, resuspended in reducing sample buffer, and subjected to SDS-PAGE on a 10% gel, according to standard procedures . Radioactive bands were visualized using a Fujix BAS 2000 Bioimage Analyzer (Fugi, Fuji Medical Systems USA Inc., Stamford, CT) . PCR and Sequencing Analysis . The following primers were used . Vy1: 5'-CCGGCAAAAAGCAAAAAAGT-3' ; Jy4: 5'-GCA-AATATCTTGACCCATGA-3' ; and pan Cy : 5'-CTTATG-GAGATTTGTTTCAGC-3' .
Genomic DNA from hybridoma cells (T and S) was prepared by the proteinase K/phenol extraction/ethanol precipitation method . Sequences spanning the V-J junction were amplified by PCR using primers specific for the Vy1 and Jy4 genes. For each sample, two PCRs were performed in parallel, each one containing either one of the primers kinased. To produce single-stranded DNA after PCR amplification, the double-stranded product was digested with X exonuclease as originally described (32) . Both strands were then sequenced by the dideoxy chain termination method using the Sequenase enzyme (United States Biochemical Corporation, Cleveland, OH) .
Total cellular RNA from hybridoma cells (BTC) was prepared by the guanidine isothiocyanate/acid phenol extraction method. cDNA was synthetized with oligo-dT using superscript reverse transcriptase (GIBCO BRL, Gaithersburg, MD) according to the manufacturer's instructions . Sequences spanning the V-J junction were amplified by PCR using primers specific for the Vyl and all Thymus-dependent and -independent Vyl-bearing 'Y/ 8 T Cells four Cy genes. After amplification, 4 wl of each PCR reaction mixture was incubated with shrimp alkaline phosphatase and exonuclease I to remove the excess of primers and dNTPs and sequenced by the dideoxy chain termination method using the Sequenase enzyme as described in the Sequenase version 2.0 DNA polymerase for sequencing PCR products kit (Pharmacia-USB).
Results
Characterization of the 2.11 mAb. The mAb 2.11 was selected by its ability to block spontaneous IL-2 production by the Vy1/V86-expressing y/8 T cell hybridoma that had been used for immunization . Initial studies showed that this mAb binds to and inhibits spontaneous IL-2 production by 10 of 10 Vyl/V86-expressing T cell hybridomas, but does not inhibit IL-2 production by ot/R-bearing T cell hybridomas (not shown) . Furthermore, the 2 .11 r Ab binds to the immunizing hybridoma cells but not to variants that have lost expression of the y/8 TCR (not shown), suggesting that the 2 .11 mAb recognizes some component of the y/8 TCR . SDS-PAGE analysis of immunoprecipitates from lysate of 125 I-surface-labeled Vy1 hybridoma cells revealed an apparently identical pattern of two bands for the 2 .11 mAb and the pan-y/8-specific mAb, 3A10 (Fig. 1 ). This confirms that the 2.11 mAb is specific for TCR-y/8.
To characterize further the specificity of the 2 .11 mAb, we stained several y/b T cell hybridomas known to express different Vy and V8 gene products . The mAb 2 .11 did not bind to previously characterized y/8 T cell hybridomas that are known to express TCRs containing Vy4, Vy5, Vy6, or Vy7 chains (30, 33) . In contrast, this mAb recognized 14 of 14 y/8 T cell hybridomas that produce IL-2 spontaneously (not shown) . Sequence analysis of rearranged y genes in those 14 hybridomas showed that all contain a functionally rearranged Vy1 gene (Fig. 2 A) . These data demonstrate that the 2 .11 mAb recognizes the Vy1-Cy4 protein but do not allow us to exclude the possibility that it also recognizes the Vy2-Cy2 protein . However, three additional lines of evidence reinforce the conclusion that the 2 .11 mAb is specific for the Vy1-Cy4 protein . (a) 2.11+ hybridomas obtained by fusion of BW5147 cells with CD4-CD8 -thymocytes that had been activated in vitro with the 2 .11 mAb all expressed a functionally rearranged Vy1-Cy4 mRNA (Fig. 2 B) , whereas they each expressed one of five different V8 genes (not shown) . (b) Immunoprecipitation of the y/8 TCR by the 2 .11 mAb performed with four different y/8 T cell hybridomas showed a 43-kD y chain compatible with the Vyl chain but incompatible with the Vy2 chain (1) . (c) Expression of functionally rearranged Vy1-Cy4 mRNA, but not of Vy2-Cy2 mRNA, correlates with the 2 .11+ phenotype in sorted 2 .11+ and 2 .11 -y/b T cell populations (Pereira, P., D . Gerber, A. Regnault, V . Hermitte, A . Coutinho, and S . Tonegawa, manuscript submitted for publication) . Taken together, these data strongly suggest that the 2 .11 mAb recognizes only the product of the Vyl-Cy4 gene.
Ontogeny of y/S T Cells Expressing the Vyl-Cy4 Gene
Product in the Thymus . Using the 2.11 mAb, we quantitated the number ofVyl-bearing y/8 thymocytes in B6 mice as a function of age . For comparison, we also determined the number of y/8 thymocytes expressing the Vy4 or the Vy5 chains using the respective antibodies that had previously been produced (1, 26) . The results are summarized in Fig.  3 . In agreement with previous results (26), Vy5-expressing thymocytes constituted the major y/8 T cell population at day 15 of gestation, but their number decreased thereafter until the first week after birth, when they became nearly undetectable. Vy4-expressing thymocytes also appeared in fetal life, and their number increased until 1 wk of age, when they represented -60% of all y/8 thymocytes. Thereafter, the number of Vy4+ thymocytes decreased to adult levels (-45% of all y/b thymocytes) . Vyl-expressing cells constituted a very minor population during fetal and early postnatal life . Their number increased rapidly 1-3 wk after birth, concomitant with the decrease of Vy4-expressing thymocytes, and quickly reached the adult levels ofaround one-third of all y/8 thymocytes (Fig. 3 A) .
In spite of the very low numbers ofVy1-expressing cells in the fetal thymus, these cells are detectable in the spleen at birth, constituting -20% of all y/8 T cells in that organ . Here again, their numbers increased very rapidly, and by 1 wk of age they reached the adult level, which is -40% of all y/8 splenic T cells in B6 mice (Fig. 3 B) .
Tissue Distribution of Vyl-Cy4-expressing y/S T Cells.
We then quantitated the proportion of Vyl-bearing y/8 T cells in the peripheral lymphoid organs and in different epithelia in adult B6, BALB/c, and C3H mice. The results are summarized in Table 1 . As can be seen, Vyl-bearing cells represent 30-50% of all y/8 T cells in the spleen and lymph nodes of the three strains studied . Given that Vy4-bearing cells also represent around half of the y/8 T cells in the peripheral lymphoid organs in these mouse strains (1, 34), these data show that Vyl-and Vy4-bearing cells comprise most of the spleen and lymph node y/8 T cells . Cells were stained and analyzed as in Fig. 2 . At least three determinations were performed except for DEC, for which the average of two experiments is given . A pool of two to five mice was used for each determination . Although y/6 T cell clones expressing a TCR composed of Vy1 and V86 chains have been isolated from the skin epithelium (18), we found that no more than 2% of the y/8-bearing DEC cells express the Vyl-Cy4 gene product in any of the three strains examined (B6, BALB/c, and C3H) .
We also found that close to 30% of the -y/8 i-IEL in B6 mice were recognized by the 2.11 mAb and were thus likely to express the Vyl gene product . This observation was surprising because previous reports analyzing mRNA expression of Vy genes in i-IEL had led to the belief that Vylbearing cells are at most a small minority of y/8 i-IEL. Stainings of B6 i-IEL with the anti-pan y/8 mAb 3A10 together with either the 2.11 mAb or an anti-V84 mAb are shown in Fig . 4 . The anti-V84 mAb recognizes a fraction of the y/8 i-IEL that is mainly included in the Vy7 + population (35) . In this particular experiment, the Vyl-bearing cells represent 28% of the y/8 i-IEL population . It is worth noting that the level ofTCR expression of Vy1 i-IEL is significantly lower than that of other y/8 TCR+ i-IEL (compare gate A in both stainings) . This has been consistently observed in many individual mice and in all three strains . We conclude that Vyl+ cells comprise a significant population of y/8 i-IEL .
Vyl-Cy4-expressing i-IEL Originate Outside the Thymus . y/8 i-IEL, as is the case for many ot/R i-IEL, have been shown to have a thymus-independent origin, as evidenced by their presence in normal numbers in athymic nude mice and in thymectomized, lethally irradiated, bone marrowreconstituted chimeras (36) (37) (38) . Furthermore, thymus-independent y/8 cells are phenotypically different from thymus dependent, peripheral y/8 T cells . Thus, whereas most peripheral y/8 T cells do not express CD4 or CD8 molecules, most of the y/8 i-IEL express the ct but not the (3 chain of the CD8 molecule (39) . Furthermore, although all peripheral y/8 T cells express the Thyl and CD5 molecules, only 30-50% ofthe y/8 i-IEL express Thyl, and all o£ them are negative for the expression of the CD5 antigen (40) (41) (42) . Given the possibility that the Vy1-bearing i-IEL population could arise from thymus-dependent peripheral Vyl cells through migration to the intestinal epithelium, we quantitated the Vyl-expressing cells in i-IEL isolated from athymic nude mice and analyzed the phenotype of Vy1-bearing Thymus-dependent and -independent Vyl-bearing y/8 T Cells Table 2 . As can be seen, the proportion of Vylbearing cells among y/8 i-IEL was very similar in normal and nude mice of all strains examined . The expression ofThyl, CD5, CD8ae, and Cd8(3 among total y/8 TCR+ or 2.11 + i-IEL in B6 mice is shown in Table 3. In concordance with previous observations (39, 41, 42) , virtually all the cells stained with the anti-8 mAb were negative for the expression of CD5 and CD8(3, whereas 80-90% of them expressed the a chain of the CD8 molecule, and close to 40% of them expressed the Thyl antigen . The 2 .11+ population displayed a very similar phenotype with regard to these markers, with most of the cells being CD5 --CD8a+(3 -. The only significant difference found between total y/8+ and 2.11 + i-IEL was the proportion of Thyl+ cells (38 and 50%, respectively) . As V-yl+ cells represented -25% of the total y/8 i-IEL in these experiments, these data imply that the Thyl antigen is expressed in 50% of the Vyl + cells and in 20% of the Vy1 -y/8 T cell population .
Normal i-IEL are constitutively cytolytic in a redirected lysis assay (6, 43) . This assay uses an Fc receptor-expressing target cell and relies on the cross-linking of TCR on effector cells by mAbs against the TCR-CD3 complex that also bind to the Fc receptor to trigger lysis . B6 i-IEL lyse P815 target cells in the presence ofthe 2.11 mAb (data not shown), Cells were stained and analyzed as in Fig. 3 . The average of two determinations is given . A pool of two to three mice was used for each determination .
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From these experiments we conclude that, similar to the V.y7+ i-IEL population, V.yl+ i-IEL also mature extrathymically, and that these y/8 T cell populations are phenotypically and functionally similar .
The Proportion of Vy1+ Cells among y/8 i-IEL Is Independent of the Antigenic Load of the Intestine. The presence of Vyl mRNA in the i-IEL population of some individual mice or in mice infected with the parasite Eimeria has been reported (44, 45) , leading to the suggestion that colonization of the gut could result in antigen-driven accumulation or expansion of a few incipient Vy1 + cells . To study the effect ofmicrobial colonization and/or food antigens on the extent of Vyl-bearing cells among y/b i-IEL, we quantitated the proportion of Vy1+ cells in i-IEL isolated from SPF and AgF BALB/c mice. The results ofone such experiment are shown in Table 4 . As can be seen, the proportion of Vyl-bearing i-IEL was virtually identical in SPF and AgF BALB/c mice. These experiments demonstrate that the presence of the Vyl-bearing population in the epithelium of the small intestine is independent of the antigenic load of the gut epithelium.
Expression of Vyl-Cy4 i-IEL in Different Mouse Strains.
We then quantitated the proportion of Vy1-bearing lymphocytes in the i-IEL population of 12 different strains of mice, including some MHC-congenic strains in different backgrounds . The results are summarized in Fig. 5 . Several conclusions can be drawn from this analysis . First, all strains Cells were stained and analyzed as in Fig . 3 . The average of two determinations is given . Three mice were used for each determination .
tested contained a sizable proportion of Vyl-bearing y/8 i-IEL that ranged from 15 to 60% of all y/8-bearing i-IEL . Second, the representation of Vyl-bearing lymphocytes among y/8 i-IEL seems to be strain specific . It should be pointed out that some of the data presented were obtained using identical strains of mice that were acquired from different sources and housed in different places . The low standard deviation observed within a single strain suggests that genetic rather than environmental factors are responsible for the observed strain-to-strain differences in the proportion of Vyl-bearing lymphocytes . Third, although differences in the percentage of y/8 i-IEL expressing the Vy1 gene product are found between MHC-congenic strains, these differences are relatively small when compared with those found between strains that differ genetically outside of the MHC locus. These data suggest that genes other than MHC genes are involved in the regulation of the number ofVy1-bearing cells .
Discussion
In this report we describe a new mAb specific for the Vy1-Cy4 chain of the y/8 TCR . The use of this mAb al-
Percent oftotal y8 WEL Figure 5 . Analysis of Vyl usage in inbred mice. i-IEL from the indicated mouse strains were analyzed for 2 .11 and 3A10 expression by fluorescence flow cytometry . Data are shown as the percentage of3A10 + cells that are 2 .11+ . When standard deviations are shown, at least three determinations were performed ; otherwise the mean of two experiments is given . Two to five mice were used for each determination . In one experiment, five 136 mice were analyzed individually . The small letter after each strain denotes the MHC haplotype . lowed us to quantitate and characterize Vy1-expessing'Y/8 T cells in the thymus offetal and adult animals, as well as in the peripheral lymphoid organs and in several epithelia. Our data, while confirming some previously drawn conclusions, revealed a few new facts about the composition of various y/8 T cell subsets in developing and adult mice. Vyl-bearing cells constitute a small minority of the y/8 thymocytes throughout fetal life. Their number increases substantially during the first weeks of postnatal life, concomitant with a decrease in the number of Vy4-bearing thymocytes. By 3 wk of age, the Vyl and Vy4 subpopulations reach their adult values of -30 and 50% of the total y/8 thymocytes, respectively . At that time, Vy5-bearing cells are virtually absent, and Vy7-bearing thymocytes represent no more than 5% of total adult y/8 thymocytes (46; Pereira, P., unpublished observations). Furthermore, although functional rearrangements of Vy6 and Vy2 genes have been described in the adult thymus (47) , it is believed that y/8 thymocytes expressing these y chains constitute a small minority among the total y/8 thymocytes . Although no other Vy genes have been identified, a possibility that some minor populations of y/8 T cells express hitherto unidentified TCR-y chains cannot be excluded. Taken together, these data are consistent with the possibility that, at least in B6 mice, other Vy genes could be expressed in the adult thymus .
In the spleen and lymph nodes, Vy1-and Vy4-bearing cells are also the major subpopulations ofthe y/8 T cell population, constituting close to 90% of all y/8 lymphocytes in these peripheral lymphoid organs . The actual proportion of Vyl-and Vy4-expressing cells varies in different strains of mice. Nevertheless, they constitute the large majority of the splenic and lymph node y/8 T cells in most ofthe common laboratory strains (34; Pereira, P., unpublished observations) . Thus, it appears that the proportions ofthe two y/8 T cell subsets are coordinated ; a decrease in the frequency of cells expressing one of these Vy chains is accompanied by a corresponding increase in the frequency of cells expressing the other Vy chain . A similar situation can be observed concerning the expression of Vy1 and Vy7 gene products within the y/8 i-IEL population. Together, Vy1-and Vy7-bearing cells represent close to 90% of the y/8 i-IEL population, and their relative frequencies in different strains ofmice are also coordinated ( Fig. 5 ; Pereira, P ., unpublished observations). This is particularly important to consider in the context of positive and/or negative selection for y/8 T cells . It has been proposed that the expansion or overrepresentation of T cells using a particular y/8 receptor could be used as an indication that positive selection has occurred (34, 38) . Although such increased representation of a specific y/8 T cell type may suggest that cellular selection has occurred, the fact that the overrepresentation of T cells using a defined Vy chain is concomitant to a similar underrepresentation of T cells using another Vy chain precludes definition of the selection as either positive or negative or both.
Although Vyl-bearing T cells have been isolated from the skin of C3H mice (18) , our data show that Vyl-bear-ing cells constitute a minor population (0.5-2%) oftotal y/8 DEC in that strain as well as in the other strains tested . On the other hand, it has been shown that the skin of nude mice is colonized by thymus-independent Vyl-bearing y/8 T cells (48) , demonstrating that these cells can home to the epithelium of the skin. Furthermore, recent analysis ofIL-7-transgenic mice that spontaneously develop dermatitis (49) has shown a massive infiltration or expansion ofy/8 T cells other than Vy5-bearing cells in the skin. It is possible, therefore, that the representation of Vyl-bearing cells in the skin epithelium is increased upon infection and could, therefore, vary in different mouse colonies .
The most striking finding concerning the tissue localization of y/8 T cells expressing the Vy1-Cy4 chain is that they constitute a substantial proportion of y/8 i-IEL in normal mice. Vy1 + cells represent 15-60% of all y/8 i-IEL in different strains of mice, and their presence is independent of the thymus and of the antigenic load of the gut . The fact that this population has been overlooked is not readily understood, although some plausible explanations can be put forward . To date, four different groups have analyzed TCR-y rearrangement or TCR-y mRNA expression in i-IEL, reaching the conclusion that the Vyl-bearing population is minor, ifnot absent, in the normal y/8 i-IEL population . The first group (50) did not analyze Vyl rearrangements in i-IEL because their previous work (7) had shown that the major y protein expressed in i-IEL had a relative molecular mass of 34-35 kD, which is clearly different from the Vyl-Cy4 protein (Mr = 41-42 kD [1]). Besides the fact that the immunoprecipitation technique is not very sensitive and is certainly not quantitative (because of the differential labeling rates of different proteins and the specificity of the antisera used), it should also be noted that the size of the Vyl-Cy4 chain is very similar to the size of most of the V8-C8 proteins . Thus, it is possible that the 8 chain band in the gels masked the Vy1-Cy4 protein .
Two other groups (51, 52) analyzed TCR-y rearrangements in i-IEL by PCR techniques using Vy-and Jy-specific primers . To analyze Vyl and Vy2 rearrangements, they used an identical set ofprimers. The Vy-specific primer crosshybridizes with Vy1 and Vy2 genes, whereas the Jy-specific primer cross-hybridizes with all four Jy sequences . A closer look at the primers used reveals that the Vy primer has a sequence identical to the Vy2 gene but contains a single mismatch with respect to the Vyl sequence in the second base at its 3' end. Similarly, the Jy primer has a sequence identical to the Jyl and Jy2 segments but has two mismatches with respect to the Jy4 segment, one of which is located in the fourth base of its 3' end. The Vy2 gene appears to be rearranged in almost all y/8 T cells and in many a/[3 T cells (Pereira, P., D. Gerber, A. Regnault, V. Hermitte, A. Coutinho, and S. Tonegawa, manuscript submitted for publication), whereas, with the exception of a small number ofother y/8 T cells, the Vyl gene is almost exclusively rearranged in cells expressing the Vyl-Cy4 protein . Thus, it seems very likely that, in the PCR conditions used by these authors, the Vy2Jy2 rearrangements would be preferentially amplified over the Vyl Jy4 rearrangements . Finally,
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the fourth group analyzed the expression of V-y mRNA in i-IEL by in situ hybridization using antisense probes but failed to detect any cells expressing either Vyl or Vy2 mRNA (53) . Further experiments conducted by these authors were limited by the preparation o£ cDNAs with a Cy1-specific primer and subsequent amplification of the cDNA with primers specific for the Vy4, Vy6, and Vy7 genes, thereby excluding Vy1-Cy4 and Vy2-Cy2 from the analysis . As this report shows no positive control for the hybridization ofany ofthe Vy-specific probes, it is possible that their failure to detect Vyl and Vy2 mRNA simply reflects the low sensitivity of the in situ hybridization technique .
We thus believe that the normal y/8 i-IEL population contains a relatively high frequency of cells expressing the Vyl-Cy4 gene product. This frequency is comparable to the frequency of cells expressing the Vy7-Cy1 chain . The frequency of the Vyl + i-IEL varies in different strains of mice but appears to be quite constant among different individuals of the same strain, even when mice are housed in different colonies. This suggests that genetic factors, rather than environmental factors, are primarily responsible for the determination ofVy1+ i-IEL frequency .
A striking characteristic ofy/8 T cell subsets is the rather strict correlation among their onset of appearance in development, the Vy (and V8) genes used to encode the TCR, and their homing to distinct peripheral sites. Thus, Vy5-and Vy6-expressing cells are primarily, if not exclusively, produced early in the fetal thymus, and home to the epithelium of skin and of uterus, vagina, and tongue, respectively (9, 26, 30, 54-57) . Vy4-bearing cells appear later in the fetal thymus, constituting the major y/8 thymocyte population at birth, and preferentially home to the peripheral lymphoid organs (1, 2, 33). Vy7-bearing cells, on the other hand, develop from precursors that do not require a thymus for maturation and home to the intestinal epithelium (36-38, 50, 51, 53) . Until this study, only a few exceptions to these rules were observed . Thus,^2% of the y/8 thymocytes bear the Vy7 protein (46) , and -5% of -1/ 8 i-IEL express the Vy4 chain in all mouse strains examined, including athymic mice (Pereira, P., unpublished observations) . In clear contrast to the other y/6 T cell subsets, the Vyl-bearing y/8 T cells seem to develop and home in a more diversified fashion. Thus, they can develop in the thymus and migrate to the peripheral lymphoid organs, where, together with the Vy4 subset, they represent the vast majority of the y/8 T cells . On the other hand, Vyl-bearing cells can also develop extrathymically and constitute, together with the Vy7 subset, the large majority of y/8 i-IEL. Thus, the ability to rearrange and express the Vy1 gene is not limited to a particular y/8 T cell precursor, nor is the differentiation ofVyl-bearing y/8 T cells restricted to a defined milieu. Thymus-independent Vyl-bearing cells have also been found in the skin of nude mice (48) , and CD8ot+ [3-y/8 T cells, which are believed to have a thymus-independent origin, have been found in the liver of normal mice (58) .
The presence of Vy1-bearing cells in lymphoid organs and epithelia might be related to their specificity . A large fraction of Vyl cells appears to recognize an endogenous antigen expressed by lymphocytes (11) . These cells can be further stimulated in the presence of PPD and HSP proteins or peptides (11, 13), which led to the suggestion that they might recognize autologous stress proteins (57, 59) . In some instances, proliferation or accumulation of Vyl-bearing cells has been shown to occur in vivo after infection of mice with different bacteria or parasites, suggesting a physiological role for those cells in the defense against pathogens (45, 60, 61) . A similar reactivity has also been described for a subset of human y/8 T cells that express the Vy9 gene product. Cells of this type respond to mycobacterial extracts We thank C. Heusser for providing us with the antigen-free mice, Elly Basel, Pam Woronof , Emily Rossie, and M. C. Vougny for excellent secretarial help, and A. Coutinho, W. Haas, and J. J. Lafaille for critical reading of the manuscript. This work was supported by Yakult Honsha Co ., Ltd., National Institutes of Health grants R37 and R35 to S. Tonegawa, and grant 6969 from the Association pour la Recherche sur le Cancer to P. Pereira. During part of this work, P. Pereira was a recipient of a fellowship from the Leukemia Society of America, and 1) . Gerber was a recipient of a National Science Foundation graduate research fellowship . 
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(and in some cases to mycobacterial and endogenous HSPs) and recognize an undefined antigen on the surface of some tumor cell lines of lymphoid origin (62) (63) (64) (65) (66) (67) (68) (69) (70) . Cells with these specificities are restricted in the use of Vy and V8 genes, but there is considerable diversity in the junctional sequences of their TCR genes (66, (71) (72) (73) (74) . As in the case of Vy1 cells in the mouse, Vy9 cells in humans appear late in ontogeny, but compose a major y/8 T cell population in adult individuals (75, 76) . This parallelism suggests a precise and important function of these cells. A precise definition of the ligands recognized by these cells will certainly help us to understand their physiological role .
Thymus-dependent and -independent Vyl-bearing y/8 T Cells
